Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity
Dawei Chen, Hampartsoum B. Barsoumian, Grant M. Fischer, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000289-e000289
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Interfering with Tumor Hypoxia for Radiotherapy Optimization
Irma Telarović, Roland H. Wenger, Martin Pruschy
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 113
Clinical development of metabolic inhibitors for oncology
Kathryn M. Lemberg, Sadakatali S. Gori, Takashi Tsukamoto, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 1
Open Access | Times Cited: 98
Role of mitochondrial alterations in human cancer progression and cancer immunity
Sheng‐Fan Wang, Ling‐Ming Tseng, Hsin‐Chen Lee
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 61
Cancer resistance and metastasis are maintained through oxidative phosphorylation
Cemile Uslu, Eda Kapan, Alex Lyakhovich
Cancer Letters (2024) Vol. 587, pp. 216705-216705
Closed Access | Times Cited: 20
Lactate and lactylation in cancer
Jie Chen, Ziyue Huang, Ya Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches
Katherine Klein, Kewen He, Ahmed I. Younes, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 88
Targeting Oxidative Phosphorylation to Increase the Efficacy of Radio- and Immune-Combination Therapy
Daan F. Boreel, Paul N. Span, Sandra Heskamp, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 11, pp. 2970-2978
Open Access | Times Cited: 74
Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection
Yuan‐Bo Pan, Wei Tang, Wenpei Fan, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 23, pp. 9759-9830
Open Access | Times Cited: 67
The Effect of Oxidative Phosphorylation on Cancer Drug Resistance
Ziyi Zhao, Yong Mei, Ziyang Wang, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 62-62
Open Access | Times Cited: 56
Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment
Mokryun L. Baek, Junegoo Lee, Katherine E. Pendleton, et al.
Oncogene (2023) Vol. 42, Iss. 14, pp. 1117-1131
Open Access | Times Cited: 33
Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondria
Rilan Bai, Jiuwei Cui
Cancer Letters (2023) Vol. 564, pp. 216223-216223
Open Access | Times Cited: 33
Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selection
Xutong Qiu, Yi Li, Zhuoyuan Zhang
Cellular Oncology (2023) Vol. 46, Iss. 4, pp. 847-865
Closed Access | Times Cited: 28
MUC20 regulated by extrachromosomal circular DNA attenuates proteasome inhibitor resistance of multiple myeloma by modulating cuproptosis
Xiaobin Wang, Yingqing Shi, Hua Shi, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 15
Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS‐010759
Marc Pujalte‐Martin, Amine Belaïd, Simon Bost, et al.
Molecular Oncology (2024) Vol. 18, Iss. 7, pp. 1719-1738
Open Access | Times Cited: 13
Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma
Jihua Tian, Jing Luo, Xing Zeng, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e008226-e008226
Open Access | Times Cited: 8
Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
Shijie Shang, Jie Liu, Vivek Verma, et al.
Cancer Communications (2021) Vol. 41, Iss. 11, pp. 1086-1099
Open Access | Times Cited: 55
OXPHOS inhibitors, metabolism and targeted therapies in cancer
Octavia Cadassou, Lars Petter Jordheim
Biochemical Pharmacology (2023) Vol. 211, pp. 115531-115531
Open Access | Times Cited: 19
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
Amr Ali, Bassem Mekhaeil, Olga‐Demetra Biziotis, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 19
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models
Gonzalo Rodríguez‐Berriguete, Rathi Puliyadi, Nicole Machado, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Nano-Assisted Radiotherapy Strategies: New Opportunities for Treatment of Non-Small Cell Lung Cancer
Lihong Zhao, Mei Li, Chen Shen, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 6
Overexpression of ESYT3 improves radioimmune responses through activating cGAS-STING pathway in lung adenocarcinoma
Zan Luo, Ying Li, Bin Xu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Interplay between Mitochondrial Metabolism and Cellular Redox State Dictates Cancer Cell Survival
Brittney Joy-Anne Foo, Jie Qing Eu, Jayshree L. Hirpara, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 34
Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light
Jie Zhang, Kang-Hui Wu, Cuicui Shi, et al.
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 12, pp. 1777-1792
Open Access | Times Cited: 26
Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs
Ammad Ahmad Farooqı, Sundas Fayyaz, Palmiro Poltronieri, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 197-207
Open Access | Times Cited: 38
Bifidobacterium breve predicts the efficacy of anti‐PD‐1 immunotherapy combined with chemotherapy in Chinese NSCLC patients
Honghui Zhao, Dan Li, Jiayin Liu, et al.
Cancer Medicine (2022) Vol. 12, Iss. 5, pp. 6325-6336
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top